Track the Onconetix, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €3m. The latest transaction was reported on 22 April 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. The full history is openly available.
22
Insider Decl.
n/a
Thresholds
€129,543
3 ops.
Buy Volume
€122,698
3 ops.
Sell Volume
32Σ signal
Buys €129,543€122,698 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Onconetix, Inc. is a company listed on the XNAS market, specializing in the development of innovative solutions for cancer diagnostics. It focuses on improving early detection methods for oncological diseases.